Furosemide
Sulfonamides, Plain
Sold as Lasix · UDSxMP Medicated System · LASIX SPECIAL
- Drug class
- Sulfonamides, Plain
- Availability
- Prescription only
- Routes
- Intravenous, Oral, Intramuscular
- Markets covered
- 3
- Products on record
- 126
- FDA reports (12 mo)
- 15,522
Overview
Furosemide is an active pharmaceutical ingredient in the Sulfonamides, Plain group (C03CA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 73 | May 29, 2026 |
| CA Canada | Health Canada | 28 | March 22, 2025 |
| US United States | FDA | 25 | March 18, 2026 |
GBUnited Kingdom· MHRA
73 products
Uses
Co-amilofruse tablets are indicated where a prompt diuresis is required. It is of particular value in conditions where potassium conservation is important; congestive cardiac failure, nephrosis, corticosteroid therapy, oestrogen therapy.
Ascites associated with cirrhosis.
How to take
CACanada· Health Canada
28 products
Uses
LASIX ORAL SOLUTION® (furosemide) is indicated for: The treatment of edema associated with congestive heart failure, cirrhosis of the liver and renal disease including, nephrotic syndrome, as well as other edematous states amenable to diuretic therapy.
The control of mild to moderate hypertension, used alone, or in combination with other antihypertensive agents in more severe cases. Hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controllable with LASIX ORAL SOLUTION alone.
1 Pediatrics When administered to children, LASIX ORAL SOLUTION therapy should be instituted in the hospital, in carefully selected patients, under close observation with frequent monitoring of serum electrolytes (see 4 DOSAGE AND ADMINISTRATION).
The available pediatric data does not allow for a recommendation of a specific age range in this population. 2 Geriatrics Geriatrics (> 65 years of age) Use in the geriatric population is associated with differences in safety. Dose selection for the elderly patients should be cautious, usually starting at the low end of dosage range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and the concomitant disease or other drug therapy.
USUnited States· FDA
25 products
Uses
INDICATIONS AND USAGE
Edema Furosemide tablets are indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Furosemide tablets are particularly useful when an agent with greater diuretic potential is desired.
Hypertension Oral furosemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. Hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with furosemide alone.
Edema Furosemide tablets are indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Furosemide tablets are particularly useful when an agent with greater diuretic potential is desired.
Drug interactions
Known interactions involving Furosemide. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 600. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL136060054 · revised July 29, 2022
- [2]Health Canada (DPD) · 02224720 · revised March 22, 2025
- [3]FDA DailyMed · 01a5f094-b473-4e… · revised March 1, 2023 [PDF]
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.